Sphingosine 1-phosphate inhibits migration and RANTES production in human bronchial smooth muscle cells
- 3 June 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 331 (2), 640-647
- https://doi.org/10.1016/j.bbrc.2005.03.223
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (15591045)
This publication has 29 references indexed in Scilit:
- Is airway remodeling clinically relevant in asthma?American Journal Of Medicine, 2003
- Respiratory syncytial virus‐induced CCL5/RANTES contributes to exacerbation of allergic airway inflammationEuropean Journal of Immunology, 2003
- Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor IsoformMolecular and Cellular Biology, 2003
- Differential Requirement of Gα12, Gα13, Gαq, and Gβγ for Endothelin-1-Induced c-Jun NH2-Terminal Kinase and Extracellular Signal-Regulated Kinase ActivationPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2003
- G Protein PathwaysScience, 2002
- Airway Inflammation and Remodeling in Asthma: Current ConceptsMolecular Biotechnology, 2002
- Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaThe FASEB Journal, 2001
- CCL Chemokines and asthmaImmunology Today, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogensNature, 1993